Allergy Treatment Crucial If Your Child Has Asthma

Title: Allergy Treatment Crucial If Your Child Has AsthmaCategory: Health NewsCreated: 6/2/2021 12:00:00 AMLast Editorial Review: 6/3/2021 12:00:00 AM
Source: MedicineNet Asthma General - Category: Respiratory Medicine Source Type: news

Related Links:

Conclusion: Present study suggests that iPROB ® preparation has clinical/biological properties to be a valid add-on supplementation in allergic patients with asthma and rhinitis.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Source Type: research
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Source Type: research
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Source Type: research
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Source Type: research
Although our understanding of asthma has been quickly developing, the more we learn, the more questions arise.1 In the asthma edition of the Annals of Allergy, Asthma&Immunology this year, several excellent articles highlight our advances in knowledge and remaining gaps.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research
Silverberg et al1 estimated the global prevalence of atopic dermatitis (AD) in the pediatric population (aged 6 months to less than 18 years) of 18 countries. Criteria used to determine AD were (1) the International Study of Asthma and Allergies in Childhood (ISAAC) criteria plus self- or parent-reported diagnosis or (2) the ISAAC criteria only. The 12-month –diagnosed AD prevalence ranged from 2.7% to 20.1% by ISAAC plus self- or parent-reported diagnosis, and it ranged from 13.5% to 41.9% by ISAAC only.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Correspondence Source Type: research
Source: Journal of Asthma and Allergy - Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research
Source: Journal of Asthma and Allergy - Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research
J Asthma. 2021 Oct 20:1-10. doi: 10.1080/02770903.2021.1996599. Online ahead of print.ABSTRACTObjective: In order to decrease the use of systemic corticosteroids and prevent asthma exacerbations, EAACI and GINA made recommendations in favour of severe asthma patients continuing the use of biologicals during the pandemic. However, the course of SARS-CoV-2 infection remains uncertain, especially in patients taking biological therapy for severe asthma. The aim of this study was to demonstrate the clinical course of COVID-19 in severe asthmatic patients receiving biological treatment. Methods: A total of 75 patients under the ...
Source: Journal of Asthma - Category: Respiratory Medicine Authors: Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | Respiratory Medicine